Agilon Health, Inc. (NYSE:AGL) Given Consensus Recommendation of "Hold" by Brokerages

Key Points

• Agilon Health, Inc. has received a consensus recommendation of "Hold" from eighteen analysts, with two sell, twelve hold, and four buy ratings.
• The company reported a quarterly loss of ($0.25) earnings per share, falling short of analysts' estimates, along with a 5.9% year-over-year decline in revenue.
• Recent analyst target price reductions for Agilon Health include a drop to as low as $1.00 from several previous estimates, indicating concerns about the stock's performance.

Agilon Health, Inc. (NYSE:AGL - Get Free Report) has received an average recommendation of "Hold" from the eighteen analysts that are currently covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, twelve have given a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month price objective among brokerages that have covered the stock in the last year is $3.0714.

AGL has been the topic of several recent analyst reports. Evercore ISI reduced their target price on shares of Agilon Health from $5.00 to $3.00 and set an "in-line" rating on the stock in a research note on Wednesday, July 9th. Benchmark reduced their target price on shares of Agilon Health from $4.00 to $1.50 and set a "buy" rating on the stock in a research note on Wednesday, August 6th. Barclays reduced their target price on shares of Agilon Health from $3.00 to $1.50 and set an "underweight" rating on the stock in a research note on Wednesday, August 6th. Robert W. Baird reduced their target price on shares of Agilon Health from $5.00 to $1.00 and set a "neutral" rating on the stock in a research note on Thursday, August 14th. Finally, Jefferies Financial Group reduced their target price on shares of Agilon Health from $2.40 to $1.10 and set a "hold" rating on the stock in a research note on Friday, August 15th.

Agilon Health Trading Down 5.7%

Shares of AGL stock opened at $1.09 on Friday. Agilon Health has a 1 year low of $0.71 and a 1 year high of $6.08. The firm's fifty day simple moving average is $1.34 and its 200 day simple moving average is $2.62. The firm has a market capitalization of $449.65 million, a P/E ratio of -1.41 and a beta of 0.11.

Agilon Health (NYSE:AGL - Get Free Report) last posted its quarterly earnings results on Monday, August 4th. The company reported ($0.25) earnings per share for the quarter, missing analysts' consensus estimates of ($0.11) by ($0.14). Agilon Health had a negative return on equity of 66.76% and a negative net margin of 5.35%.The business had revenue of $1.39 billion for the quarter, compared to analyst estimates of $1.47 billion. During the same quarter in the prior year, the firm earned ($0.07) EPS. The firm's quarterly revenue was down 5.9% on a year-over-year basis. Equities research analysts anticipate that Agilon Health will post -0.59 EPS for the current fiscal year.

Institutional Trading of Agilon Health

Institutional investors and hedge funds have recently added to or reduced their stakes in the company. State of Wyoming increased its stake in shares of Agilon Health by 31.1% in the 2nd quarter. State of Wyoming now owns 168,461 shares of the company's stock valued at $387,000 after acquiring an additional 39,952 shares during the last quarter. Caxton Associates LLP increased its stake in shares of Agilon Health by 8.5% in the 2nd quarter. Caxton Associates LLP now owns 382,868 shares of the company's stock valued at $881,000 after acquiring an additional 29,843 shares during the last quarter. Tower Research Capital LLC TRC increased its stake in shares of Agilon Health by 214.0% in the 2nd quarter. Tower Research Capital LLC TRC now owns 37,079 shares of the company's stock valued at $85,000 after acquiring an additional 25,270 shares during the last quarter. Engineers Gate Manager LP increased its stake in shares of Agilon Health by 63.1% in the 2nd quarter. Engineers Gate Manager LP now owns 1,148,970 shares of the company's stock valued at $2,643,000 after acquiring an additional 444,358 shares during the last quarter. Finally, Brevan Howard Capital Management LP increased its stake in shares of Agilon Health by 36.7% in the 2nd quarter. Brevan Howard Capital Management LP now owns 325,385 shares of the company's stock valued at $748,000 after acquiring an additional 87,403 shares during the last quarter.

Agilon Health Company Profile

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.